
Global Diammonium Glycyrrhizinate Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Diammonium Glycyrrhizinate market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Diammonium Glycyrrhizinate market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Diammonium Glycyrrhizinate market include Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Diammonium Glycyrrhizinate, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Diammonium Glycyrrhizinate, also provides the value of main regions and countries. Of the upcoming market potential for Diammonium Glycyrrhizinate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diammonium Glycyrrhizinate revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Diammonium Glycyrrhizinate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Diammonium Glycyrrhizinate company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Diammonium Glycyrrhizinate Segment by Company
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
Suzhou Erye Pharmaceutical Co. Ltd
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
Jiangsu Tiansheng Pharmaceutical Co. Ltd
Sinopharm Guorui Pharmaceutical Co. Ltd
ND Pharma & Biotech Co. Ltd.
Diammonium Glycyrrhizinate Segment by Type
Injection
Capsule
Diammonium Glycyrrhizinate Segment by Application
Chronic Viral Hepatitis
Immune Regulation
Diammonium Glycyrrhizinate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Diammonium Glycyrrhizinate status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Diammonium Glycyrrhizinate key companies, revenue, market share, and recent developments.
3. To split the Diammonium Glycyrrhizinate breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Diammonium Glycyrrhizinate market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Diammonium Glycyrrhizinate significant trends, drivers, influence factors in global and regions.
6. To analyze Diammonium Glycyrrhizinate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diammonium Glycyrrhizinate industry.
Chapter 3: Detailed analysis of Diammonium Glycyrrhizinate company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Diammonium Glycyrrhizinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Diammonium Glycyrrhizinate in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
According to APO Research, the global Diammonium Glycyrrhizinate market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Diammonium Glycyrrhizinate market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Diammonium Glycyrrhizinate market include Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Diammonium Glycyrrhizinate, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Diammonium Glycyrrhizinate, also provides the value of main regions and countries. Of the upcoming market potential for Diammonium Glycyrrhizinate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diammonium Glycyrrhizinate revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Diammonium Glycyrrhizinate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Diammonium Glycyrrhizinate company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Diammonium Glycyrrhizinate Segment by Company
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
Suzhou Erye Pharmaceutical Co. Ltd
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
Jiangsu Tiansheng Pharmaceutical Co. Ltd
Sinopharm Guorui Pharmaceutical Co. Ltd
ND Pharma & Biotech Co. Ltd.
Diammonium Glycyrrhizinate Segment by Type
Injection
Capsule
Diammonium Glycyrrhizinate Segment by Application
Chronic Viral Hepatitis
Immune Regulation
Diammonium Glycyrrhizinate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Diammonium Glycyrrhizinate status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Diammonium Glycyrrhizinate key companies, revenue, market share, and recent developments.
3. To split the Diammonium Glycyrrhizinate breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Diammonium Glycyrrhizinate market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Diammonium Glycyrrhizinate significant trends, drivers, influence factors in global and regions.
6. To analyze Diammonium Glycyrrhizinate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diammonium Glycyrrhizinate industry.
Chapter 3: Detailed analysis of Diammonium Glycyrrhizinate company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Diammonium Glycyrrhizinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Diammonium Glycyrrhizinate in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Table of Contents
195 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Diammonium Glycyrrhizinate Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Diammonium Glycyrrhizinate Market Size (2020-2031)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Diammonium Glycyrrhizinate Market Dynamics
- 2.1 Diammonium Glycyrrhizinate Industry Trends
- 2.2 Diammonium Glycyrrhizinate Industry Drivers
- 2.3 Diammonium Glycyrrhizinate Industry Opportunities and Challenges
- 2.4 Diammonium Glycyrrhizinate Industry Restraints
- 3 Diammonium Glycyrrhizinate Market by Company
- 3.1 Global Diammonium Glycyrrhizinate Company Revenue Ranking in 2024
- 3.2 Global Diammonium Glycyrrhizinate Revenue by Company (2020-2025)
- 3.3 Global Diammonium Glycyrrhizinate Company Ranking (2023-2025)
- 3.4 Global Diammonium Glycyrrhizinate Company Manufacturing Base and Headquarters
- 3.5 Global Diammonium Glycyrrhizinate Company Product Type and Application
- 3.6 Global Diammonium Glycyrrhizinate Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Diammonium Glycyrrhizinate Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.7.3 2024 Diammonium Glycyrrhizinate Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
- 4 Diammonium Glycyrrhizinate Market by Type
- 4.1 Diammonium Glycyrrhizinate Type Introduction
- 4.1.1 Injection
- 4.1.2 Capsule
- 4.2 Global Diammonium Glycyrrhizinate Sales Value by Type
- 4.2.1 Global Diammonium Glycyrrhizinate Sales Value by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Diammonium Glycyrrhizinate Sales Value by Type (2020-2031)
- 4.2.3 Global Diammonium Glycyrrhizinate Sales Value Share by Type (2020-2031)
- 5 Diammonium Glycyrrhizinate Market by Application
- 5.1 Diammonium Glycyrrhizinate Application Introduction
- 5.1.1 Chronic Viral Hepatitis
- 5.1.2 Immune Regulation
- 5.2 Global Diammonium Glycyrrhizinate Sales Value by Application
- 5.2.1 Global Diammonium Glycyrrhizinate Sales Value by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Diammonium Glycyrrhizinate Sales Value by Application (2020-2031)
- 5.2.3 Global Diammonium Glycyrrhizinate Sales Value Share by Application (2020-2031)
- 6 Diammonium Glycyrrhizinate Regional Value Analysis
- 6.1 Global Diammonium Glycyrrhizinate Sales Value by Region: 2020 VS 2024 VS 2031
- 6.2 Global Diammonium Glycyrrhizinate Sales Value by Region (2020-2031)
- 6.2.1 Global Diammonium Glycyrrhizinate Sales Value by Region: 2020-2025
- 6.2.2 Global Diammonium Glycyrrhizinate Sales Value by Region (2026-2031)
- 6.3 North America
- 6.3.1 North America Diammonium Glycyrrhizinate Sales Value (2020-2031)
- 6.3.2 North America Diammonium Glycyrrhizinate Sales Value Share by Country, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Diammonium Glycyrrhizinate Sales Value (2020-2031)
- 6.4.2 Europe Diammonium Glycyrrhizinate Sales Value Share by Country, 2024 VS 2031
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Diammonium Glycyrrhizinate Sales Value (2020-2031)
- 6.5.2 Asia-Pacific Diammonium Glycyrrhizinate Sales Value Share by Country, 2024 VS 2031
- 6.6 South America
- 6.6.1 South America Diammonium Glycyrrhizinate Sales Value (2020-2031)
- 6.6.2 South America Diammonium Glycyrrhizinate Sales Value Share by Country, 2024 VS 2031
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Diammonium Glycyrrhizinate Sales Value (2020-2031)
- 6.7.2 Middle East & Africa Diammonium Glycyrrhizinate Sales Value Share by Country, 2024 VS 2031
- 7 Diammonium Glycyrrhizinate Country-level Value Analysis
- 7.1 Global Diammonium Glycyrrhizinate Sales Value by Country: 2020 VS 2024 VS 2031
- 7.2 Global Diammonium Glycyrrhizinate Sales Value by Country (2020-2031)
- 7.2.1 Global Diammonium Glycyrrhizinate Sales Value by Country (2020-2025)
- 7.2.2 Global Diammonium Glycyrrhizinate Sales Value by Country (2026-2031)
- 7.3 USA
- 7.3.1 USA Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.3.2 USA Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.3.3 USA Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.4 Canada
- 7.4.1 Canada Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.4.2 Canada Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.4.3 Canada Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.5 Mexico
- 7.5.1 Mexico Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.5.2 Mexico Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.5.3 Mexico Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.6 Germany
- 7.6.1 Germany Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.6.2 Germany Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Germany Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.7 France
- 7.7.1 France Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.7.2 France Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.7.3 France Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.8 U.K.
- 7.8.1 U.K. Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.8.2 U.K. Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.8.3 U.K. Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.9 Italy
- 7.9.1 Italy Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.9.2 Italy Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.9.3 Italy Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.10 Spain
- 7.10.1 Spain Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.10.2 Spain Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.10.3 Spain Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.11 Russia
- 7.11.1 Russia Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.11.2 Russia Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Russia Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.12 Netherlands
- 7.12.1 Netherlands Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.12.2 Netherlands Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Netherlands Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.13.2 Nordic Countries Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Nordic Countries Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.14 China
- 7.14.1 China Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.14.2 China Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.14.3 China Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.15 Japan
- 7.15.1 Japan Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.15.2 Japan Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Japan Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.16 South Korea
- 7.16.1 South Korea Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.16.2 South Korea Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.16.3 South Korea Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.17 India
- 7.17.1 India Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.17.2 India Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.17.3 India Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.18 Australia
- 7.18.1 Australia Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.18.2 Australia Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.18.3 Australia Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.19.2 Southeast Asia Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.19.3 Southeast Asia Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.20 Brazil
- 7.20.1 Brazil Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.20.2 Brazil Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Brazil Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.21 Argentina
- 7.21.1 Argentina Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.21.2 Argentina Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Argentina Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.22 Chile
- 7.22.1 Chile Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.22.2 Chile Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Chile Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.23 Colombia
- 7.23.1 Colombia Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.23.2 Colombia Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Colombia Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.24 Peru
- 7.24.1 Peru Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.24.2 Peru Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Peru Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.25.2 Saudi Arabia Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Saudi Arabia Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.26 Israel
- 7.26.1 Israel Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.26.2 Israel Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Israel Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.27 UAE
- 7.27.1 UAE Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.27.2 UAE Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.27.3 UAE Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.28 Turkey
- 7.28.1 Turkey Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.28.2 Turkey Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Turkey Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.29 Iran
- 7.29.1 Iran Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.29.2 Iran Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.29.3 Iran Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 7.30 Egypt
- 7.30.1 Egypt Diammonium Glycyrrhizinate Sales Value Growth Rate (2020-2031)
- 7.30.2 Egypt Diammonium Glycyrrhizinate Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Egypt Diammonium Glycyrrhizinate Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd
- 8.1.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Comapny Information
- 8.1.2 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview
- 8.1.3 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.1.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 8.1.5 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Developments
- 8.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
- 8.2.1 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Comapny Information
- 8.2.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview
- 8.2.3 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.2.4 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 8.2.5 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Developments
- 8.3 Suzhou Erye Pharmaceutical Co. Ltd
- 8.3.1 Suzhou Erye Pharmaceutical Co. Ltd Comapny Information
- 8.3.2 Suzhou Erye Pharmaceutical Co. Ltd Business Overview
- 8.3.3 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.3.4 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 8.3.5 Suzhou Erye Pharmaceutical Co. Ltd Recent Developments
- 8.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
- 8.4.1 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Comapny Information
- 8.4.2 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview
- 8.4.3 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.4.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio
- 8.4.5 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Developments
- 8.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd
- 8.5.1 Jiangsu Tiansheng Pharmaceutical Co. Ltd Comapny Information
- 8.5.2 Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview
- 8.5.3 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.5.4 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 8.5.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Developments
- 8.6 Sinopharm Guorui Pharmaceutical Co. Ltd
- 8.6.1 Sinopharm Guorui Pharmaceutical Co. Ltd Comapny Information
- 8.6.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
- 8.6.3 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.6.4 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 8.6.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Developments
- 8.7 ND Pharma & Biotech Co. Ltd.
- 8.7.1 ND Pharma & Biotech Co. Ltd. Comapny Information
- 8.7.2 ND Pharma & Biotech Co. Ltd. Business Overview
- 8.7.3 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
- 8.7.4 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio
- 8.7.5 ND Pharma & Biotech Co. Ltd. Recent Developments
- 9 Concluding Insights
- 10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.